
AI Digest · Hims & Hers and Noom launch peptide programs after HHS eases compounding
Both telehealth companies will now offer peptide prescriptions to eligible patients. The US Department of Health and Human Services made it easier for pharmacies to offer BPC-157. The Before November contract on an FDA move to Category 1 settled No. The Before 2027 contract is still trading and was unchanged over the last day. Many compounded peptides sold to consumers are experimental and lack FDA approval. Category 1 placement would restore the ability of compounding pharmacies to make BPC-157.